|?|| (A;A) (A;G) (G;G) ||28|
, and rs2267668
in PPARD affect Lifestyle Intervention induced changes in overall adiposity, hepatic fat storage, and relative muscle mass. Our findings provide a mechanistic explanation for the involvement of these genetic variations in the development of insulin resistance and type-2 diabetes
|Desc||PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD|
|Desc||PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA;|
] The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome
(PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence
[PMID 17327385] Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
[PMID 21331343] The myocyte expression of adiponectin receptors and PPARdelta is highly coordinated and reflects lipid metabolism of the human donors.
[PMID 23186209] Mitochondriogenesis genes and extreme longevity.